Guided by QbD, we provide comprehensive analytical method development and validation in accordance with ICH Q2 based on CQA to support oral dosage form development.
Crystal Pharmatech will conduct analytical service by strictly following the cGMP regulations of NMPA, FDA, and EMA, as well as technical and quality agreement (TQA) with our customers.
According to the different stages of drug products, we will use corresponding strategies to complete the testing and release of API, excipients and packaging materials under GMP.
